BML Investment Partners, L.P. 13D/13G Filings for OnKure Therapeutics, Inc. (OKUR)

BML Investment Partners, L.P. 13D and 13G filings for OnKure Therapeutics, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2024-10-09
11:40 am
Purchase
2024-10-0913GOnKure Therapeutics, Inc.
OKUR
BML Investment Partners, L.P.447,815
3.500%
447,815increase
(New Position)
Filing